These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9605164)

  • 1. Prevention and treatment of experimental autoimmune encephalomyelitis by CNI-1493, a macrophage-deactivating agent.
    Martiney JA; Rajan AJ; Charles PC; Cerami A; Ulrich PC; Macphail S; Tracey KJ; Brosnan CF
    J Immunol; 1998 Jun; 160(11):5588-95. PubMed ID: 9605164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1.
    Johns LD; Flanders KC; Ranges GE; Sriram S
    J Immunol; 1991 Sep; 147(6):1792-6. PubMed ID: 1716279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline.
    Bright JJ; Du C; Coon M; Sriram S; Klaus SJ
    J Immunol; 1998 Dec; 161(12):7015-22. PubMed ID: 9862738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
    Roscoe WA; Welsh ME; Carter DE; Karlik SJ
    J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
    Jung EJ; Hur M; Kim YL; Lee GH; Kim J; Kim I; Lee M; Han HK; Kim MS; Hwang S; Kim S; Woo AM; Yoon Y; Park HJ; Won J
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1005-13. PubMed ID: 19741152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of experimental autoimmune encephalomyelitis by ghrelin.
    Theil MM; Miyake S; Mizuno M; Tomi C; Croxford JL; Hosoda H; Theil J; von Hörsten S; Yokote H; Chiba A; Lin Y; Oki S; Akamizu T; Kangawa K; Yamamura T
    J Immunol; 2009 Aug; 183(4):2859-66. PubMed ID: 19620309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
    Wang Y; Mei Y; Feng D; Xu L
    J Neurosci Res; 2008 Aug; 86(11):2441-9. PubMed ID: 18438925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis.
    Li FQ; Sempowski GD; McKenna SE; Laskowitz DT; Colton CA; Vitek MP
    J Pharmacol Exp Ther; 2006 Sep; 318(3):956-65. PubMed ID: 16740622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idazoxan attenuates spinal cord injury by enhanced astrocytic activation and reduced microglial activation in rat experimental autoimmune encephalomyelitis.
    Wang XS; Chen YY; Shang XF; Zhu ZG; Chen GQ; Han Z; Shao B; Yang HM; Xu HQ; Chen JF; Zheng RY
    Brain Res; 2009 Feb; 1253():198-209. PubMed ID: 19083996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genistein down-modulates pro-inflammatory cytokines and reverses clinical signs of experimental autoimmune encephalomyelitis.
    De Paula ML; Rodrigues DH; Teixeira HC; Barsante MM; Souza MA; Ferreira AP
    Int Immunopharmacol; 2008 Sep; 8(9):1291-7. PubMed ID: 18602076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metallothionein treatment reduces proinflammatory cytokines IL-6 and TNF-alpha and apoptotic cell death during experimental autoimmune encephalomyelitis (EAE).
    Penkowa M; Hidalgo J
    Exp Neurol; 2001 Jul; 170(1):1-14. PubMed ID: 11421579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice.
    Tran EH; Hoekstra K; van Rooijen N; Dijkstra CD; Owens T
    J Immunol; 1998 Oct; 161(7):3767-75. PubMed ID: 9759903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation.
    Fu YF; Zhu YN; Ni J; Zhong XG; Tang W; Re YD; Shi LP; Wan J; Yang YF; Yuan C; Nan FJ; Lawson BR; Zuo JP
    J Pharmacol Exp Ther; 2006 Nov; 319(2):799-808. PubMed ID: 16914558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis.
    Savino C; Pedotti R; Baggi F; Ubiali F; Gallo B; Nava S; Bigini P; Barbera S; Fumagalli E; Mennini T; Vezzani A; Rizzi M; Coleman T; Cerami A; Brines M; Ghezzi P; Bianchi R
    J Neuroimmunol; 2006 Mar; 172(1-2):27-37. PubMed ID: 16337691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis.
    Morini M; Roccatagliata L; Dell'Eva R; Pedemonte E; Furlan R; Minghelli S; Giunti D; Pfeffer U; Marchese M; Noonan D; Mancardi G; Albini A; Uccelli A
    J Neuroimmunol; 2004 Mar; 148(1-2):146-53. PubMed ID: 14975595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligodendrocyte-specific protein peptides induce experimental autoimmune encephalomyelitis in SJL/J mice.
    Stevens DB; Chen K; Seitz RS; Sercarz EE; Bronstein JM
    J Immunol; 1999 Jun; 162(12):7501-9. PubMed ID: 10358205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribavirin reduces clinical signs and pathological changes of experimental autoimmune encephalomyelitis in Dark Agouti rats.
    Milicevic I; Pekovic S; Subasic S; Mostarica-Stojkovic M; Stosic-Grujicic S; Medic-Mijacevic L; Pejanovic V; Rakic L; Stojiljkovic M
    J Neurosci Res; 2003 Apr; 72(2):268-78. PubMed ID: 12672002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (5R)-5-hydroxytriptolide (LLDT-8), a novel triptolide derivative, prevents experimental autoimmune encephalomyelitis via inhibiting T cell activation.
    Fu YF; Zhu YN; Ni J; Zhong XG; Tang W; Zhou R; Zhou Y; Dong JR; He PL; Wan H; Li YC; Yang YF; Zuo JP
    J Neuroimmunol; 2006 Jun; 175(1-2):142-51. PubMed ID: 16712960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis.
    Furlan R; Kurne A; Bergami A; Brambilla E; Maucci R; Gasparini L; Butti E; Comi G; Ongini E; Martino G
    J Neuroimmunol; 2004 May; 150(1-2):10-9. PubMed ID: 15081244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment with atorvastatin and minocycline suppresses severity of EAE.
    Luccarini I; Ballerini C; Biagioli T; Biamonte F; Bellucci A; Rosi MC; Grossi C; Massacesi L; Casamenti F
    Exp Neurol; 2008 May; 211(1):214-26. PubMed ID: 18346732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.